Cargando…
Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
The mutation profile of the SARS-CoV-2 Omicron (lineage BA.1) variant posed a concern for naturally acquired and vaccine-induced immunity. We investigated the ability of prior infection with an early SARS-CoV-2 ancestral isolate (Australia/VIC01/2020, VIC01) to protect against disease caused by BA.1...
Ejemplares similares
-
SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
por: Handley, Alastair, et al.
Publicado: (2023) -
The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
por: Davies, Elizabeth R., et al.
Publicado: (2023) -
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
por: Coombes, Naomi S., et al.
Publicado: (2023) -
Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection
por: Dowall, Stuart, et al.
Publicado: (2021) -
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
por: Ryan, Kathryn A., et al.
Publicado: (2021)